ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Heartland Dental may be looking to sell its 350 practices for up to $1.4B

September 5, 2012 6:37 pm by | 0 Comments

Heartland Dental for sale

NEW YORK (Reuters) - Heartland Dental Care Inc, one of the largest dental practice management companies in the United States, is exploring a sale that could fetch as much as $1.4 billion, according to two people familiar with the matter.

The company, in which Chicago-based private equity firm CHS Capital Partners has a stake, has hired investment banks Jefferies and Moelis to find a buyer and has drawn interest mostly from other buyout firms, the people said.

The sources asked not to be identified because the process is not public.

Heartland Dental has about $120 million in annual earnings before interest, tax, depreciation and amortization (EBITDA) and could be sold for 10 to 12 times EBITDA, they added.

Advertisement

The auction is early in the second round and final bids are expected about a month from now, according to the people. Jefferies has offered to provide financing for potential buyers, they added.

Representatives for Heartland Dental, CHS Capital, Jefferies and Moelis did not immediately respond to requests for comment.

Effingham, Illinois-based Heartland Dental manages more than 350 affiliated dental practices in 19 U.S. states, providing dentists with administrative services such as personnel staffing, purchasing, and financial, marketing and technology support, according to its website.

The company is owned and operated by founder and Chief Executive Rick Workman, a dentist. CHS Capital made a minority equity investment in 2008 for an undisclosed sum.

(Reporting by Soyoung Kim in New York; Editing by Phil Berlowitz)

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Related Topics: , ,
0 comments

Stay Up To Date

Recent Comments

Research Center

Jobs Board

Next Story
Maker of stem cell modulators brings in $9.2 million for blood cancer trials
Close